ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 865

Abdominal Visceral Adipose Tissue Measured By Dual Energy X-Ray Absorptiometry (DXA) As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides

Bertrand Dunogué1, Karine Briot2, Sami Kolta2, Alexis Regent1, Pascal Cohen1, Alice Berezne1, Xavier Puéchal1, Claire Le Jeunne1, Luc Mouthon1, Christian Roux2, Loïc Guillevin1 and Benjamin Terrier1, 1Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, 2Rheumatology B Department, Hôpital Cochin, Paris, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: adipose tissue, Cardiovascular disease, DXA, osteoporosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Studies have shown a strong prevalence of cardiovascular events among patients with systemic necrotizing vasculitides (SNV). Recent studies indicate that visceral adipose tissue (VAT) is highly associated with cardiovascular events. The aim of this study was to assess the relevance of abdominal adipose tissue measurement by Dual energy X-ray Absorptiometry (DXA) as a potential surrogate marker for cardiovascular risk in patients with SNV.

Methods: Patients with SNV seen in our department were prospectively included in a cross-sectional study assessing cardio-vascular complications and risk factors, and other sequelae. DXA was performed to evaluate body composition and abdominal adipose tissue (both subcutaneous (SAT) and visceral (VAT)).

Results: One hundred and twenty consecutive patients with SNV were analyzed (66 female and 54 male, mean age 53±18 years, median disease duration of 54 months). Diagnoses were granulomatosis with polyangiitis in 61 patients, eosinophilic granulomatosis with polyangiitis in 30, polyarteritis nodosa in 14, microscopic polyangiitis in 13, and cryoglobulinemia vasculitis in 2. The median daily dose of glucocorticoids was 8.5 mg/day (0-80), with an estimated total cumulative dose of 15000±10000 mg of glucocorticoids.

High cardiovascular risk, as defined by the NCEP-ATPIII, was present in 28 (23.3%) patients, including 15 (12.5%) with previous cardiovascular disease. Variables significantly associated with high cardiovascular risk after multivariate analysis were an increased age [OR 1.04 (1.00-1.08); P=0.048] and an increased VAT/SAT ratio [OR 1.06 (1.03-1.09); P<0.0001]. The VAT/SAT ratio was significantly higher in patients with high cardiovascular risk (66.3±21.2 vs. 39.4±18.2%, P<0.0001), particularly those with previous cardiovascular history (75.2±13.4 vs. 41.1±19.5%, P<0.0001). A higher VAT/SAT ratio was independently associated with increased age (P<0.0001), male gender (P<0.0001), and elevated levels of triglycerides (P=0.01), glycated hemoglobin (P=0.007) and troponin (P=0.05).

The Framingham cardiovascular risk score, predicting a subject’s risk of developing an ischemic cardiac disease in the next 10 years, was strongly correlated with the VAT/SAT ratio in our patients (r=+0.60, P<0.0001), but also with the 10-year probability of major osteoporotic (r=+0.35, P=0.0009) and hip (r=+0.51, P<0.0001) fractures using the FRAX.

Conclusion: This is the first study showing a significant association between a high VAT/SAT ratio assessed by DXA and cardiovascular risk in patients with SNV. The measurement of the abdominal adipose tissue seems to be an accurate and independent surrogate marker of cardiovascular risk in these patients. Finally, cardiovascular and osteoporotic fracture risks were strongly associated suggesting that optimal management of both risks is crucial in these patients.


Disclosure: B. Dunogué, None; K. Briot, None; S. Kolta, None; A. Regent, None; P. Cohen, None; A. Berezne, None; X. Puéchal, None; C. Le Jeunne, None; L. Mouthon, None; C. Roux, None; L. Guillevin, None; B. Terrier, None.

To cite this abstract in AMA style:

Dunogué B, Briot K, Kolta S, Regent A, Cohen P, Berezne A, Puéchal X, Le Jeunne C, Mouthon L, Roux C, Guillevin L, Terrier B. Abdominal Visceral Adipose Tissue Measured By Dual Energy X-Ray Absorptiometry (DXA) As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/abdominal-visceral-adipose-tissue-measured-by-dual-energy-x-ray-absorptiometry-dxa-as-a-novel-surrogate-marker-of-cardiovascular-risk-in-primary-necrotizing-vasculitides/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abdominal-visceral-adipose-tissue-measured-by-dual-energy-x-ray-absorptiometry-dxa-as-a-novel-surrogate-marker-of-cardiovascular-risk-in-primary-necrotizing-vasculitides/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology